TransTech Pharma has inked a collaboration agreement with Boehringer Ingelheim worth up to $54 million in up front payments, milestones and research support. TransTech also stands to gain royalties from any approved products. TransTech will use its TTP Translational Technology to discover novel molecules.
- read this release for more information